Efficacy and Safety of Famitinib Versus Sunitinib in the Treatment of Advanced Gastrointestinal Stromal Tumour Patients After Failure of Imatinib
Clinical trial NCT04409223 · TERMINATED
Trial details
- NCT number
- NCT04409223
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-12
- Primary completion
- 2022-03-25
- Enrollment
- 185
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.